JB

Jonathan Behr

Investing in, and building, life science companies

Cambridge, Massachusetts

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Board Observer

    2024

  • Partner

    2019

    The Dementia Discovery Fund (DDF) is a venture capital fund, delivering both high-impact therapeutics for age related dementias and financial returns by investing in, creating, and supporting innovative companies. I am responsible for helping to build the Fund’s investment portfolio by leading investments in new and established companies, working closely with the Fund’s existing portfolio companies in advisor and director roles, and developing and driving DDF’s investment strategy in collaboration with the leadership team. The DDF is managed by SV Health Investors, a healthcare and life sciences venture capital and growth equity firm.

  • Partner

    2019

  • Board Observer

    2024

  • Member Board of Directors

    2023

  • Member Board of Directors

    2020

2020

  • Board Observer

    2022

  • Member Board of Directors

    2020 - 2022

  • Board Observer

    2022

  • Board Observer

    2022

  • Independent Director, Parkinson's Research Ventures Ltd.

    2023

    The Parkinson’s UK Virtual Biotech (VB) programme was established in 2016 as a patient-led programme to discover and develop new treatments for Parkinson’s. It represents a core element of the strategy of the Parkinson’s UK charity (the “Charity”) to accelerate breakthroughs in research. Parkinson's Research Ventures (PRV) is a wholly-owned subsidiary of the Charity and was established in 2018 as a vehicle through which many of the financing and IP transactions for the VB Programme would be pursued. I am a volunteer independent director on the board of PRV.